MBC Board of Directors

Chair Mark Leuchtenberger Targanta Therapeutics
Vice-Chair Geoffrey F. Cox GTC Biotherapeutics, Inc.
Treasurer Michael W. O'Hara Deloitte & Touche LLP
Clerk Glenn Batchelder BIND BioSciences, Inc.
Immediate Past Chair Michael D. Webb Ascent Therapeutics, Inc.

Board Members

  Mark R. Bamforth Genzyme Corporation
  Erroll De Souza Archemix Corporation
  Jeffrey J. Elton Novartis Institutes for BioMedical Research, Inc.
  W. Stephen Faraci Pfizer, Inc.
  Fereydoun Firouz EMD Serono, Inc.
  Scott H. Gillis Formerly of NUCRYST Pharmaceuticals
  John K. Hennessy AstraZeneca R&D Boston
  Timothy Hunt Biogen Idec
  Edwin M. Kania, Jr. Flagship Ventures
  Michael Kowolenko Wyeth Biotech and Wyeth Research Headquarters
  Laurie Bartlett Keating Millenium Pharmaceuticals
  David J. McLachlan Emeritus
  Judy Ozbun New England Healthcare Institute
  Steven G. Richter MicroTest Laboratories, Inc.
  Amit Sachdev Vertex Pharmaceuticals, Inc.
  Frank Thomas
  Lawrence S. Wittenberg Goodwin Procter LLP

Counsel

Legislative William P. McDermott McDermott, Quilty & Miller LLP
Communication Robert Gottlieb Feinstein Kean Healthcare